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Dermal bacterial LPS‑stimulation 
reduces susceptibility 
to intradermal Trypanosoma brucei 
infection
Omar A. Alfituri, Enock M. Mararo, Pieter C. Steketee, Liam J. Morrison & Neil A. Mabbott*
Infections with Trypanosoma brucei sp. are established after the injection of metacyclic 
trypomastigotes into the skin dermis by the tsetse fly vector. The parasites then gain access to the 
local lymphatic vessels to infect the local draining lymph nodes and disseminate systemically via the 
bloodstream. Macrophages are considered to play an important role in host protection during the 
early stage of systemic trypanosome infections. Macrophages are abundant in the skin dermis, but 
relatively little is known of their impact on susceptibility to intradermal (ID) trypanosome infections. 
We show that although dermal injection of colony stimulating factor 1 (CSF1) increased the local 
abundance of macrophages in the skin, this did not affect susceptibility to ID T. brucei infection. 
However, bacterial LPS‑stimulation in the dermis prior to ID trypanosome infection significantly 
reduced disease susceptibility. In vitro assays showed that LPS‑stimulated macrophage‑like 
RAW264.7 cells had enhanced cytotoxicity towards T. brucei, implying that dermal LPS‑treatment 
may similarly enhance the ability of dermal macrophages to eliminate ID injected T. brucei parasites 
in the skin. A thorough understanding of the factors that reduce susceptibility to ID injected T. brucei 
infections may lead to the development of novel strategies to help reduce the transmission of African 
trypanosomes.
African trypanosomes are single-celled protozoan parasites that are transmitted between mammals throughout 
sub-Saharan Africa by blood-feeding tsetse flies of the genus Glossina. Human African trypanosomiasis is caused 
by infection with the Trypanosoma brucei rhodesiense and T. b. gambiense sub-species, whereas animal African 
trypanosomiasis is caused by infection with T. congolense, T. vivax and T. b. brucei. The trypanosome life-cycle 
within the mammalian host begins after the intradermal (ID) injection of metacyclic trypomastigote forms into 
the skin dermis by blood-feeding tsetse flies. Once within the skin dermis, the parasites undergo adaptation to 
the mammalian host and directly invade the  lymphatics1,2 to access the local draining lymph nodes, before dis-
seminating systemically via the bloodstream. During this initial establishment phase, the parasites also undergo 
a morphological change into the long-slender blood-stream forms that exist entirely extracellularly within the 
mammalian  host2–5.
Much of our understanding of the host–pathogen interactions that influence mammalian trypanosome infec-
tions has been obtained from the study of experimental transmissions to mice infected via the intraperitoneal 
or intravenous routes. However, relatively little is known of the factors that are important in controlling disease 
progression following the natural ID route of infection. Mononuclear phagocytes (MNP) are a heterogeneous 
population of monocytes, macrophages, classical dendritic cells and tissue-specific phagocytes including the 
Kupffer cells in the liver, the microglia in the brain and the Langerhans cells of the skin epidermis. These cells are 
derived from haematopoietic precursors and are dependent on stimulation from the cytokine colony stimulat-
ing factor 1 (CSF1) for their  development6. Kupffer cells in mice can readily phagocytose antibody-opsonized 
T. congolense  parasites7, and data from experimental systemic transmissions show that macrophages play an 
important role in protection during the early stage of trypanosome infections by helping to limit the magnitude 
of the first parasitaemic  wave8,9. MNP are abundant in the skin dermis, but little is known of their impact on ID 
trypanosome infections. The gradual accumulation of monocytes in the dermis after ID trypanosome injection 
has been reported, but these cells were not considered to play a significant role in parasite  clearance10. Therefore, 
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in the current study we determined the separate effects of increased abundance of MNP in the dermis and dermal 
LPS-stimulation on susceptibility to ID infection with T. brucei parasites in mice.
Results
Intradermal CSF1‑Fc treatment increases the local abundance of CSF1R + MNP in the skin. Sys-
temic administration of a CSF1-Fc conjugate significantly expands the abundance of colony stimulating factor 
1 receptor (CSF1R)-expressing MNP in  tissues11. We therefore used transgenic Csf1r-EGFP reporter mice to 
determine the effects of ID CSF1-Fc treatment on the local abundance of CSF1R + MNP in the skin. In these 
mice, EGFP expression is driven by the Csf1r promoter and stably and reliably reflects the expression of CSF1R 
 protein12. In tissues from Csf1r-EGFP reporter mice all the MNP populations are labelled, even under circum-
stances where Csf1r mRNA is  depleted12. The only other EGFP-expressing cells in these mice are the trophoblasts 
in the placenta that express Csf1r from a unique promoter. To restrict the effects of CSF1-administration to the 
dermis, groups of four mice were injected ID into the ear pinna with CSF1-Fc, or an equivalent volume of PBS as 
a control, for 3 days. Approximately 24 h after the final CSF1-Fc treatment the abundance of Csf1r-EGFP+ MNP 
in the vicinity of the injection site was then quantified microscopically (Fig. 1A). This analysis showed that the 
number of  EGFP+ MNP in the dermis was significantly increased in CSF1-Fc-treated Csf1r-EGFP+ mice when 
compared to PBS-treated controls (Fig. 1B; P = 0.001, Student’s t-test).
Intradermal CSF1‑Fc treatment does not affect susceptibility to ID T. brucei infection. Next, 
groups of eight non-transgenic C57BL/6J mice were injected ID into the ear pinna with CSF1-Fc, or PBS as a 
control, as above, and 24 h after the final CSF1-Fc treatment the mice were injected ID with 1 ×  105 T. brucei 
STIB 247 parasites into the same site. Blood parasitaemias were then measured at daily intervals for 30 d post-
infection using the rapid matching  method13, which has a minimum detection limit of approximately 4 ×  105 
parasites/mL of blood. These data showed that parasite kinetics after ID trypanosome injection were similar in 
mice from each treatment group. All the CSF1-Fc-treated and PBS-treated mice developed a parasitaemia that 
was first detectable from around 5 d post-infection, with similar parasite burdens detected at the peak of the 
first parasitaemia wave (Fig. 2; PBS 6 ×  106 parasites/mL; CSF1-Fc, 3 ×  106 parasites/mL; P = 0.1984, Student’s 
Figure 1.  Enhanced abundance of Csf1r-EGFP + mononuclear phagocytes (MNP) in the dermis of Csf1r-
EGFP+ mice after intradermal (ID) injection with CSF1-Fc. (A) Csf1r-EGFP reporter mice were injected ID 
with CSF1-Fc, or PBS as a control, for three days and 24 h after the final injection the ears were removed and 
viewed using a 2-photon microscope. Images show EGFP + MNP (green, arrowheads) and background collagen 
signal (purple) in the dermis. Arrows, auto-fluorescent hair follicles. (B) The numbers of EGFP + MNP in the 
dermis local to the injection site were significantly increased after CSF1-Fc-treatment when compared to PBS-
treated controls (P = 0.001, Student’s t-test; CSF1-Fc, n = 4; PBS, n = 3).
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t-test, n = 8). Following the initial parasitaemia wave, a similar proportion of the mice in each treatment group 
displayed transient relapses in their parasitaemias during the remainder of the experiment (PBS, 4/8 mice; CSF1-
Fc, 3/8 mice). Together, these data show that although the local abundance of CSF1R + MNP increased signifi-
cantly in the dermis after CSF1-Fc treatment, this did not affect susceptibility to ID T. brucei infection.
ID LPS treatment decreases susceptibility to ID T. brucei infection. We next determined whether 
LPS-stimulation directly within the dermis would influence susceptibility to ID T. brucei infection. Groups of 
Csf1r-EGFP reporter mice were injected ID with LPS, or an equivalent volume of PBS as a control, and 24 h later 
the abundance of Csf1r-EGFP + MNP cells in the dermis local to the injection site was determined as above. 
This analysis suggested that ID LPS exposure did not affect the local abundance of Csf1r-EGFP+ MNP as similar 
numbers were observed in the dermis of PBS-treated control mice (Fig. 3A).
To determine the effects of ID LPS-stimulation on susceptibility to ID trypanosome infection, groups of 
C57BL/6J mice were first injected ID into the ear pinna with LPS (or PBS as a control) and 24 h later injected ID 
with 1 ×  105 T. brucei STIB 247 parasites into the same site. The blood parasitaemia was then monitored for 30 d. 
Whereas all of the PBS-treated mice developed a detectable parasitaemia, only 5/8 LPS-treated mice had detect-
able parasitaemias during the 30 d observation period (Fig. 3B). The magnitude of the mean parasite burdens 
at the peak of the first wave in those mice that developed a detectable parasitaemia also differed significantly 
between treatment groups (PBS, 6 ×  106 parasites/mL; LPS, 8 ×  105 parasites/mL; P = 0.0365, Student’s t-test). 
These data demonstrate that LPS-stimulation directly with the skin dermis significantly reduces susceptibility 
to ID trypanosome infection.
Figure 2.  Intradermal CSF1-Fc treatment does not affect susceptibility to ID T. brucei infection. Groups of 
C57BL/6J mice were injected ID with CSF1-Fc, or PBS as a control, for three consecutive days and 24 h after the 
final injection the mice were injected ID with a 1 ×  105 dose of T. brucei STIB 247 parasites (n = 8 mice/group). 
Heatmap shows the  log10 number of trypanosomes/mL of blood on each day after ID infection. Each row 
represents an individual mouse. UD = below detection limit (~ 5.4  log10 parasites/mL blood).
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Figure 3.  ID LPS treatment decreases susceptibility to ID T. brucei infection. (A) Csf1r-EGFP reporter mice 
were injected ID with LPS, or PBS as a control, and 24 h later the abundance of EGFP + MNP cells in the dermis 
local to the injection site determined as in Fig. 1. Similar numbers of  EGFP+ MNP were observed in the ear 
following ID LPS or PBS treatment (n = 2–3 mice/group). (B) Groups of C57BL/6 J mice were injected ID with 
LPS, or PBS as a control, and 24 h later injected with ID with a 1 ×  105 dose of T. brucei STIB 247 parasites (n = 8 
mice/group). Heatmap shows the  log10 number of trypanosomes/mL of blood on each day after ID infection. 
Each row represents an individual mouse. UD = below detection limit of 5.4  log10 parasites/mL.
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LPS treatment enhances the ability of macrophage‑like RAW264.7 cells to kill T. brucei in 
vitro. MNP have been suggested to play an important role in trypanosome infections by phagocytosing and 
destroying the parasites and via the production of cytotoxic/cytostatic  mediators14,15. Bacterial LPS is a potent 
pathogen-associated molecular pattern that elicits a strong immune response in MNP via Toll-like receptor 
(TLR)-4  signalling16. Thus, although LPS treatment did not affect the abundance of CSF1R + MNP in the dermis, 
it is plausible that the pro-inflammatory properties of LPS-stimulated MNP enhanced their ability to clear the 
parasites from the injection site and thus reduce the initial parasitaemic peak. To test this hypothesis, murine 
macrophage-like RAW264.7  cells17 were stimulated with LPS (or PBS as a control) and co-cultivated in vitro with 
T. brucei STIB 247 parasites. The number of viable parasites was then determined 24 h later. Stimulation with 
LPS enhanced the ability of RAW264.7 cells to kill T. brucei as the number of viable trypanosomes detected after 
co-cultivation in the presence of these cells was significantly reduced (Fig. 4A).
Trypanosome-derived ketoacids such as indolepyruvate can reduce the production of inflammatory media-
tors by LPS-stimulated macrophages including pro-inflammatory cytokines and the toxic free radical nitric 
oxide (NO)18,19. Production and excretion of these metabolites may enable the trypanosomes to evade clear-
ance by activated MNP. Consistent with this hypothesis, high levels of nitrite (a stable NO reaction product) 
were detected in the wells of the LPS-stimulated RAW264.7 cells, and this was reduced to background levels 
in the presence of indolepyruvate (Fig. 4B). Furthermore, treatment with indolepyruvate limited the ability of 
LPS-stimulated RAW264.7 cells to kill T. brucei (Fig. 4C). These data imply that ID LPS-treatment may have 
induced the production of pro-inflammatory mediators such as NO in local CSF1R + MNP, and these may have 
enhanced their ability to clear the parasites from the infection  site20. However, it is plausible that the production 
of trypanosome-derived metabolites such as indolepyruvate may offer some protection against this.
Discussion
Macrophages are considered to play an important role in protection during the early stages of African trypano-
some infections in mammalian hosts by phagocytosing antibody-opsonized parasites, and producing cytotoxic 
and inflammatory  mediators21–23. For example, the release of parasite-derived CpG DNA and soluble glyco-
sylphosphatidyl inositol (GPI)-anchored variant surface glycoprotein stimulates the macrophages in a TLR-
dependent manner to adopt a pro-inflammatory phenotype that is important for controlling the early stages 
of  infection21,24–26. Although MNP are abundant in the skin, little is known of their impact on ID trypanosome 
 infections21. We therefore studied the effects of increased MNP abundance or activation in the skin on suscepti-
bility to ID trypanosome infection. We show that the CSF1-mediated increase in the abundance of MNP at the 
site of ID trypanosome infection did not affect the infection kinetics. However, bacterial LPS-stimulation in the 
dermis 24 h before ID trypanosome infection significantly reduced the parasitaemia, with only a proportion 
of the mice developing a detectable parasitaemia throughout the 30 d observation period. The stimulation of 
macrophages with bacterial LPS rapidly induces a pro-inflammatory transcriptional  response27,28, and in vitro 
assays showed that LPS-stimulated RAW264.7 cells had enhanced cytotoxicity towards T. brucei. Together, our 
data suggest that the stimulation of dermal MNP with LPS may enhance their ability to eliminate ID injected T. 
brucei parasites in the skin.
Further studies are now required to identify the mechanism responsible for the LPS-mediated increased 
protection against ID trypanosome infection. Although only a small number of Csf1r-EGFP+ MNP were avail-
able for analysis, our data suggested that LPS stimulation did not affect the abundance of CSF1R + MNP in the 
dermis. Data from an ex vivo human skin organ culture model show that LPS-treatment induces the expression 
of high levels of pro-inflammatory cytokines, including interleukin (IL)-1β, IL-6, IL-8 and tumour necrosis 
factor-α29. Expression of these pro-inflammatory mediators may stimulate the activation of skin-resident innate 
immune cell populations, or aid the recruitment of neutrophils and other inflammatory MNP. Neutrophils, but 
not macrophages, express CD300f. highly in murine skin, and interactions between ceramide and CD300f. can 
suppress neutrophil accumulation and oedema in LPS-induced skin  inflammation30. This implies that increased 
oedema and neutrophil accumulation are unlikely to be significant factors that contribute to the decreased sus-
ceptibility to ID trypanosome infection observed in LPS-treated mice. This is consistent with data suggesting 
that neutrophils do not contribute to the control of ID trypanosome  infections10. Although neutrophils were 
rapidly recruited to the tsetse fly bite site after T. brucei  infection10,31, these cells rarely engulfed the parasites and 
disease susceptibility was not affected by their  absence10. Studies using mice with TLR-4 expression conditionally 
ablated in dermal MNP would help resolve whether the effects of LPS-treatment on ID T. brucei infection are 
specifically mediated through these cells.
Bacterial LPS is potent stimulator of the L-arginine NO  pathway32, and in MNP this leads to the synthesis 
of high levels of the cytotoxic free radical NO via expression of the enzyme inducible NO synthase (iNOS)33,34. 
The production of high levels of NO by inflammatory MNP is important for the clearance of many intracellular 
pathogens. The macrophage response during the early stages of trypanosome infections in mice and humans 
is also accompanied by elevated NO  production35,36. In vitro studies show that macrophage-derived NO can 
similarly mediate toxicity to extracellular  trypansomes37. However, NO can bind to haemoglobin with high affin-
ity, suggesting that in the extracellular environment of the mammalian host’s bloodstream, its toxicity against 
trypanosomes is  reduced15. Macrophage-derived NO may also trigger iron loss within  trypanosomes37, whereas 
another study has shown that it may react with serum albumin to produce S-nitroso-albumin that also has anti-
parasitic  effects14. Therefore, although NO may be inefficient at killing extracellular trypanosomes within the 
bloodstream, it could be highly effective within the microenvironment of the extravascular tissue spaces in the 
skin during the early stages following ID infection. In the current study, the enhanced ability of LPS-stimulated 
RAW264.7 cells to kill T. brucei in vitro also coincided with their ability to produce high levels of NO. Further 
in vivo studies, for example using iNOS-deficient mice or iNOS inhibitors, are clearly necessary to determine 
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Figure 4.  Enhanced ability of LPS-stimulated RAW264.7 cells to kill T. brucei. (A) Macrophage-like RAW264.7 
cells were stimulated with 10 µg LPS (or PBS as a control), co-cultivated with T. brucei STIB 247 parasites, and 
the number of viable parasites determined 24 h later. (B,C) Macrophage-like RAW264.7 cells were stimulated 
with 10 µg LPS and/or 1 mM indolepyruvate, and then co-cultivated with T. brucei STIB 247 parasites. 
Twenty four hours later (B) nitrite levels in the culture supernatant, and (C) the number of viable parasites 
were determined. Data are shown as the mean ± SD for 3 wells/group from an individual experiment, and are 
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whether the effects of LPS-stimulation on susceptibility to ID trypanosome infection are mediated through 
enhanced NO production by MNP in the skin.
The duration of the effect of LPS-treatment on the MNP at the injection site was not determined. Soon after 
injection into the dermis by tsetse flies the trypanosomes can be visualised migrating towards and within the 
lymphatics in the  skin1 and can be detected within the draining lymph nodes by 18  h2. In our study the mice 
were injected with a single dose of LPS into the dermis of the ear pinna. This would suggest that the effects of 
LPS stimulation were most likely restricted to the early stages of the infection within the skin dermis, and would 
have had little influence once the parasites had disseminated beyond this site.
While LPS-stimulated MNP may be effective in killing T. brucei, metabolites produced by the trypanosomes 
such as aromatic ketoacids could help to protect them against this  activity18,19. For example, trypanosome-derived 
indolepyruvate inhibits the LPS-induced glycolytic shift in  macrophages18. This leads to reduced expression of 
the transcription factor hypoxia-inducible factor-1α and decreased expression of pro-inflammatory mediators 
including  NO18,19. Consistent with this potential immune evasion property, the treatment of LPS-stimulated 
RAW264.7 cells with 1 mM indolepyruvate reduced their ability to kill T. brucei and produce NO. However, since 
susceptibility to ID T. brucei infection was significantly reduced in the LPS-treated mice it is uncertain whether 
trypanosome-derived indolepyruvate had any influence during the early stages of the infection in the dermis. 
McGettrick and  colleagues18 reported that the levels of aromatic ketoacids in the serum of T. brucei infected 
rats were typically in the range of 0.2–0.5 mM when their parasitaemias reached ~  108 parasites/mL. This would 
imply that the levels of indolepyruvate produced by the trypanosomes in the dermis soon after injection may 
be insufficient to have a significant impact on the responses of the local MNP. However, the concentrations 
and kinetics of such secreted molecules in extravascular microenvironments like the skin dermis would be an 
interesting aspect for further study.
Dermal CSF1-Fc treatment, in contrast, did not affect disease susceptibility despite increasing the abundance 
of MNP in the skin in the vicinity of the infection site. The stimulation of macrophages with CSF1 induces 
their polarisation towards an “alternatively-activated” or M2 phenotype, which includes the production of high 
levels of anti-inflammatory cytokines such as IL-10 and transforming growth factor-β38,39. These alternatively-
activated macrophages can also dampen pro-inflammatory host responses towards certain  pathogens40, and can 
secrete factors that mediate fibrosis or help repair the tissue damage caused by chronic infections with helminth 
parasites such as  schistosomes41,42. In alternatively activated MNP, expression of the enzyme arginase competes 
with iNOS for the substrate  arginine43, producing ornithine and urea instead of NO and citrulline. CSF1R-
signalling in MNP similarly inhibits iNOS activity in MNP and skews the cells towards arginase  expression44. A 
pro-inflammatory macrophage response is considered important for initial control during the early stages of a 
trypanosome  infection9. Thus, it is plausible that CSF1-Fc treatment polarised the MNP in the dermis towards 
an alternatively-activated phenotype that may be less effective at clearing the ID-injected parasites from the skin. 
Despite this, disease susceptibility was not increased by CSF1-Fc treatment. As discussed  above1,2, it is likely that 
there is only a short period between injection and the initial dissemination during which the MNP in the skin 
will have opportunity to significantly impact on disease pathogenesis.
Animal African trypanosome infections continue to inflict significant economic strain on sub-Saharan Afri-
can livestock industries. Although a small number of trypanocidal drugs have been developed and are used in the 
field, drug-resistance can significantly impede their efficacy. We show that dermal LPS-stimulation significantly 
reduces susceptibility to ID T. brucei infection in mice. A thorough understanding of the cellular and molecular 
mechanisms that mediate this protection may lead to the development of novel strategies to help reduce the 
transmission of African trypanosomes.
Materials and methods
Mice. Six to eight weeks old female C57BL/6 J mice (Charles River, Harlow, England) and Csf1r-EGFP ‘mac 
green’  mice12 maintained on a C57BL/6 background were used where indicated. Mice were housed in individu-
ally ventilated cages with food and water provided ad libitum. All in vivo procedures were carried out under the 
authority of the appropriate project and personal licenses, in accordance with the United Kingdom Home Office 
regulations and the Animals (Scientific Procedures) Act 1986. Approvals for all the in vivo studies were obtained 
from The Roslin Institute’s and University of Edinburgh’s ethics committees, and these ensured they were carried 
out in compliance with the ARRIVE guidelines and recommendations.
Trypanosomes. Pleomorphic wild-type T. b. brucei strain STIB247 were used throughout this study. These 
trypanosomes were originally isolated in 1971 from a hartebeeste (Alcelaphus buselaphus) in the Serengeti 
National Park,  Tanzania45. The trypanosomes were axenically cultivated in vitro as previously  described1. Prior 
to their use in each in  vivo experiment, approximately 1 ×  105 axenically cultivated trypanosomes were first 
injected by the intraperitoneal route into C57BL/6J mice to obtain a fresh source of in vivo-adapted parasites. 
Blood was collected from these mice at the first peak of parasitaemia wave and used as a source of in vivo adapted 
trypanosomes in subsequent experiments. In these experiments, groups of female C57BL/6J mice were injected 
ID with approximately 1 ×  105 T. b. brucei STIB247 in vivo adapted parasites.
Blood parasitaemias were assessed at daily intervals using the rapid matching  method13. Briefly, the number 
of trypanosomes was counted in wet blood films within 5 or 20 microscope fields depending on the parasite 
density. These values were then matched to the number of parasites/mL of blood based on data in an established 
reference table derived from haemocytometer counts of trypanosomes in infected blood samples. This assay has 
a minimum detection limit of approximately 4 ×  105 parasites/mL of blood.
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Intradermal injection with CSF1‑Fc and bacterial LPS. Where indicated, female C57BL/6 J mice and 
Csf1r-EGFP+ mice (6–8 weeks old) were injected ID with 1 mg/kg of a recombinant porcine CSF1-Fc  conjugate46 
in a 10 µL volume into the ear pinna for three consecutive days. For bacterial LPS stimulation, mice were given 
a single ID injection into the ear pinna with LPS from Escherichia coli O111:B4 (10 µg/10 µL; Sigma-Aldrich, 
Gillingham, UK) in PBS.
Whole‑mount fluorescence multi‑photon microscopy. Mouse ears were excised and immobilised on 
an imaging platform using tissue adhesive glue (3 M Vetbond, 3 M, St. Paul, MN, USA) and suspended in PBS 
before being imaged on a Zeiss LSM7MP 2-photon microscope (Carl Zeiss Ltd., Cambridge, UK). The micro-
scope was equipped with a 20X/1.0NA water-immersion objective lens (Carl Zeiss Ltd), a coherent titanium-
sapphire laser and an optical parametric oscillator (wavelength range 690 to 1400 nm). A laser output of 880 nm 
provided the excitation for the EGFP.
RAW264.7 cells and co‑culture with trypanosomes. Prior to use in studies, macrophage-like 
RAW264.7  cells17 were cultured in 100  mm2 plates (Sterilin Ltd., Newport, Gwent, UK) at 37 °C in a humidified 
5%  CO2/air atmosphere in 18 mL complete RPMI media (RPMI-1640, 5% heat-inactivated foetal bovine serum, 
200 mM GlutaMAX, 5000 μg/mL penicillin–streptomycin; ThermoFisher Scientific, Paisley, UK). Cells were 
passaged every 3–4 days when they had reached a density of approximately 2 ×  106 cells/10 mL medium.
For co-culture experiments, RAW264.7 cells (1 ×  105) were stimulated with 10 µg LPS (or PBS as a control) and 
co-cultured with 1 ×  106 STIB247 trypanosomes per well in 24 well tissue culture plates (ThermoFisher Scientific). 
In some experiments indolepyruvate (indole-3-pyruvic acid; Sigma-Aldrich) dissolved in absolute ethanol was 
included at a final concentration of 1 mM. Triplicate wells were used for each treatment group. The plates were 
incubated for 24 h at 37 °C in a humidified 5%  CO2/air atmosphere. The number of viable trypanosomes in each 
well was then counted using a haemocytometer. Experiments were repeated at least three times on separate days.
Nitrite detection. Nitrite levels in culture supernatants were determined by Griess assay using a commer-
cial kit (Griess Reagent System; Promega, Southampton, UK). Briefly, 50 µL of culture supernatant was added 
to triplicate wells of a clear 96-well plate. Plates also included a standard curve generated from serial dilutions 
of a nitrite standard ranging from 100–1.56 µM. Sulphanilamide solution (50 µL) was added to each well and 
incubated at room temperature for 10  min, before addition of N-1-napthylethylenediamine dihydrochloride 
solution. Plates were shaken and incubated for a further 10 min before absorbance was read at 550 nm.
Statistics. Data are presented as mean ± SD. Unless indicated otherwise, statistical differences between 
groups were compared by Student’s t-test using GraphPad Prism v.8.0 software (GraphPad Software Inc. San 
Diego, USA). P values ≤ 0.05 were accepted as significant. A linear mixed effects model in RStudio (rstudio.com) 
was used to statistically compare the quadratic (squared) and cubic curve effect of the infected mouse parasitae-
mia across the observation period. Mean peak parasitaemias were compared by Student’s t-test.
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